Raphaël Duivenvoorden, theme Renal disorders, and colleagues, looked at the immune response of patients admitted to the hospital with a SARS-CoV-2 infection. They observed that monocytes, play an important role in the first line of defense against the coronavirus. Therefore, they investigated the effect of hydroxychloroquine on these cells. They have discovered an as yet unknown effect of hydroxychloroquine. It inhibits trained immunity, which is important in the first line of defense against infections. That is why they expect hydroxychloroquine to have no beneficial effect on the immune response in a SARS-CoV-2 infection.
They have published these findings in MedRxiv: Hydroxychloroquine inhibits trained immunity - implications for COVID-19 - Nils Rother, Cansu Yanginlar, Rik G.H. Lindeboom, Siroon Bekkering, Mandy M.T. van Leent, Baranca Buijsers, Inge Jonkman, Mark de Graaf, Marijke Baltissen, Lieke A. Lamers, Niels P. Riksen, Zahi A. Fayad, Willem J.M. Mulder, Luuk B. Hilbrands, Leo A.B. Joosten, Mihai G. Netea, Michiel Vermeulen, Johan van der Vlag, Raphaël Duivenvoorden. Articles in MedRxiv are not peer-reviewed.
Raphaël explained on the Dutch TV (NPO Op 1) about this research. You can wath this here.
Related news items
Grants for research on magnesium deficiency and malaria Vidis for Felix Hol and Jeroen de Baaij1 July 2022 Radboudumc researchers Jeroen de Baaij and Felix Hol both receive an NWO Vidi grant for their research, respectively on magnesium deficiency in type 2 diabetes and on malaria. read more
Field research on malaria vaccine offers unexpected surprise23 May 2022
Field research on the effectiveness of a malaria vaccine, came up with unexpected results for an international group of researchers including Benjamin Mordmüller of Radboudumc. The vaccine evokes a broader response against malaria proteins than there are in the vaccine.read more